DOCSLIB.ORG

Methylation - from Dna, Rna and Histones to Diseases and Treatment

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Methylation - from Dna, Rna and Histones to Diseases and Treatment METHYLATION - FROM DNA, RNA AND HISTONES TO DISEASES AND TREATMENT Edited by Anica Dricu Methylation - From DNA, RNA and Histones to Diseases and Treatment http://dx.doi.org/10.5772/2932 Edited by Anica Dricu Contributors Anica Dricu, Dmitri Nikitin, Attila Kertesz-Farkas2, Alexander Solonin, Marina Mokrishcheva, Hirokazu Suzuki, Robert Peter Mason, Mark Brown, Xian Wang, Hongchuan Jin, Elena Kubareva, Alexandra Ryazanova, Liudmila Abrosimova, Tatiana Oretskaya, Zvonko Magic, Gordana Supic, Nebojsa Jovic, Mirjana Brankovic-Magic, Jianrong Li, Rita Castro, Byron Baron Published by InTech Janeza Trdine 9, 51000 Rijeka, Croatia Copyright © 2013 InTech All chapters are Open Access distributed under the Creative Commons Attribution 3.0 license, which allows users to download, copy and build upon published articles even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. After this work has been published by InTech, authors have the right to republish it, in whole or part, in any publication of which they are the author, and to make other personal use of the work. Any republication, referencing or personal use of the work must explicitly identify the original source. Notice Statements and opinions expressed in the chapters are these of the individual contributors and not necessarily those of the editors or publisher. No responsibility is accepted for the accuracy of information contained in the published chapters. The publisher assumes no responsibility for any damage or injury to persons or property arising out of the use of any materials, instructions, methods or ideas contained in the book. Publishing Process Manager Iva Simcic Technical Editor InTech DTP team Cover InTech Design team First published February, 2013 Printed in Croatia A free online edition of this book is available at www.intechopen.com Additional hard copies can be obtained from [email protected] Methylation - From DNA, RNA and Histones to Diseases and Treatment , Edited by Anica Dricu p. cm. ISBN 978-953-51-0881-8 free online editions of InTech Books and Journals can be found at www.intechopen.com Contents Preface VII Section 1 Gene Expression and Methylation 1 Chapter 1 Breaking the Silence: The Interplay Between Transcription Factors and DNA Methylation 3 Byron Baron Section 2 DNA-Methyltransferases: Structure and Function in Eukaryotic and Prokaryotic System 27 Chapter 2 Diverse Domains of (Cytosine-5)-DNA Methyltransferases: Structural and Functional Characterization 29 A. Yu. Ryazanova, L. A. Abrosimova, T. S. Oretskaya and E. A. Kubareva Chapter 3 Bifunctional Prokaryotic DNA-Methyltransferases 71 Dmitry V. Nikitin, Attila Kertesz-Farkas, Alexander S. Solonin and Marina L. Mokrishcheva Section 3 Protein Arginine Methylation in Mammals 89 Chapter 4 Deciphering Protein Arginine Methylation in Mammals 91 Ruben Esse, Paula Leandro, Isabel Rivera, Isabel Tavares de Almeida, Henk J Blom and Rita Castro Section 4 Cancer Research Through Study of Methylation Cell Processes 117 Chapter 5 Methylation in Tumorigenesis 119 Melissa A. Edwards, Pashayar P. Lookian, Drew R. Neavin and Mark A. Brown VI Contents Chapter 6 Circulating Methylated DNA as Biomarkers for Cancer Detection 137 Hongchuan Jin, Yanning Ma, Qi Shen and Xian Wang Chapter 7 DNA Methylation, Stem Cells and Cancer 153 Anica Dricu, Stefana Oana Purcaru, Alice Sandra Buteica, Daniela Elise Tache, Oana Daianu, Bogdan Stoleru, Amelia Mihaela Dobrescu, Tiberiu Daianu and Ligia Gabriela Tataranu Chapter 8 DNA Methylation in the Pathogenesis of Head and Neck Cancer 185 Zvonko Magić, Gordana Supić, Mirjana Branković-Magić and Nebojša Jović Section 5 Bacteria, Viruses and Metals Methylation: Risk and Benefit for Human Health 217 Chapter 9 Host-Mimicking Strategies in DNA Methylation for Improved Bacterial Transformation 219 Hirokazu Suzuki Chapter 10 Messenger RNA Cap Methylation in Vesicular Stomatitis Virus, a Prototype of Non‐Segmented Negative‐Sense RNA Virus 237 Jianrong Li and Yu Zhang Chapter 11 The Methylation of Metals and Metalloids in Aquatic Systems 271 Robert P. Mason Preface There is a widespread interest in the today scientific literature for methylation field, which started to be published in the early 60’s and continues to be a future line of research. This book represents a comprehensively reviewed literature on the importance of methylation processes in human health and disease. The book, covers the basic mechanism of DNA and protein methylation, along with the role of mRNA cap methylation in viral replication, gene expression and viral pathogenesis. Human health risks from metals methylation in the natu‐ ral environment has been well describe in the literature. As a consequence, the formation processes, the biotic and abiotic degradation and the accumulation of the methylated metals and metalloids in the aquatic environment is reviwed in the book. DNA methylation is a well-characterized process, allowing cells to control gene expression, while the study of histone methylation is more recent. The enzymes responsible for histone methylation (histone methyltransferases and histone demethylases) are important for tran‐ scriptional regulation in both normal and abnormal states, representing an important target for drug discovery. The interconection between DNA methylation and other regulatory mol‐ ecules such as: enzymes, transcription factors, proteins and growth factors is discussed, pro‐ viding key information about the mechanisms that trigger cell proliferation, differentiation, aging and malignant transformation. This textbook strongly point out the importance of me‐ thylated DNA as a biological marker of cancer an also gives the reader insights into the re‐ cently emerged treatment modalities targeting methylation mechanism, in various diseases including cancer. The textbook addresses the following topics: Gene expression and methylation, DNA-meth‐ yltransferases: structure and function in eukaryotic and prokaryotic system; Protein arginine methylation in mammals; Cancer research through study of methylation cell processes; Bac‐ teria, viruses and metals methylation: risk and benefit for human health. The book aims at the advanced undergraduate and graduate biomedical students and re‐ searchers working in the epigenetic area, providing readers with both classical and relevant recent discoveries that have been made in the research field of methylation and also point‐ ing out pathways where questions remain. Prof. Anica Dricu University of Medicine and Pharmacy Faculty of Medicine Craiova, Romania Section 1 Gene Expression and Methylation Chapter 1 Breaking the Silence: The Interplay Between Transcription Factors and DNA Methylation Byron Baron Additional information is available at the end of the chapter http://dx.doi.org/10.5772/55021 1. Introduction DNA methylation is best known for its role in gene silencing through a methyl group (CH3) being added to the 5' carbon of cytosine bases (giving 5-methylcytosine) in the promoters of genes leading to supression of transcription [1]. However this is far from the whole story. De novo methylation, which involves the addition of a methyl group to unmodified DNA, is described as an epigenetic change because it is a chemical modification to DNA not a change brought about by a DNA mutation. Unlike mutations, methylation changes are potentially reversible. Epigenetic changes also include changes to DNA-associated molecules such as histone modifications, chromatin-remodelling complexes and other small non-coding RNAs including miRNAs and siRNAs [2]. These changes have key roles in imprinting (gene-ex‐ pression dependent on parental origin), X chromosome inactivation and heterochromatin formation among others [3-5]. DNA methylation leading to silencing is a very important survival mechanism used on re‐ petitive sequences in the human genome, which come from DNA and RNA viruses or from mRNA and tRNA molecules that are able to replicate independently of the host genome. Such elements need to be controlled from spreading throughout the genome, by being si‐ lenced through CpG methylation, as they cause genetic instability and activation of onco‐ genes [6-10]. Such elements can be categorised into three groups: SINEs (Small Interspersed Nuclear Elements), LINEs (Long Interspersed Nuclear Elements) and LTRs (Long Terminal Repeats) [6,11-13]. Repetitive sequences are recognised by Lymphoid-Specific Helicase (LSH) also known as the ‘heterochromatin guardian’ [14,15], which additionally acts on sin‐ gle-copy genes [16]. © 2013 Baron; licensee InTech. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 4 Methylation - From DNA, RNARNA andand Histones Histones to to Diseases Diseases and and Treatment Treatment DNA methylation generally occurs when a cytosine is adjacent 5’ to a guanine, called a CpG di‐ nucleotide. Such dinucleotides are spread all over the genome and over 70% of CpGs are me‐ thylated. Clusters of CpGs, called CpG Islands (CGI), consist of stretches of 200–4000bp that are 60 to 70% G/C rich, found in TATAless promoters and/or first exons of genes [17-19]. In the human genome almost 50% of transcription start sites (TSS) [20], and about 70% of all genes contain CGIs [21,22]. CGIs present in the promoters or first exons
Load more

Recommended publications
  • Restriction Endonucleases
    Molecular Biology Problem Solver: A Laboratory Guide. Edited by Alan S. Gerstein Copyright © 2001 by Wiley-Liss, Inc. ISBNs: 0-471-37972-7 (Paper); 0-471-22390-5 (Electronic) 9 Restriction Endonucleases Derek Robinson, Paul R. Walsh, and Joseph A. Bonventre Background Information . 226 Which Restriction Enzymes Are Commercially Available? . 226 Why Are Some Enzymes More Expensive Than Others? . 227 What Can You Do to Reduce the Cost of Working with Restriction Enzymes? . 228 If You Could Select among Several Restriction Enzymes for Your Application, What Criteria Should You Consider to Make the Most Appropriate Choice? . 229 What Are the General Properties of Restriction Endonucleases? . 232 What Insight Is Provided by a Restriction Enzyme’s Quality Control Data? . 233 How Stable Are Restriction Enzymes? . 236 How Stable Are Diluted Restriction Enzymes? . 236 Simple Digests . 236 How Should You Set up a Simple Restriction Digest? . 236 Is It Wise to Modify the Suggested Reaction Conditions? . 237 Complex Restriction Digestions . 239 How Can a Substrate Affect the Restriction Digest? . 239 Should You Alter the Reaction Volume and DNA Concentration? . 241 Double Digests: Simultaneous or Sequential? . 242 225 Genomic Digests . 244 When Preparing Genomic DNA for Southern Blotting, How Can You Determine If Complete Digestion Has Been Obtained? . 244 What Are Your Options If You Must Create Additional Rare or Unique Restriction Sites? . 247 Troubleshooting . 255 What Can Cause a Simple Restriction Digest to Fail? . 255 The Volume of Enzyme in the Vial Appears Very Low. Did Leakage Occur during Shipment? . 259 The Enzyme Shipment Sat on the Shipping Dock for Two Days.
    [Show full text]
  • Genome‐Wide Association Studies of the Self‐Rating of Effects of Ethanol (SRE)
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by eScholarship - University of California UC San Diego UC San Diego Previously Published Works Title Genome-wide association studies of the self-rating of effects of ethanol (SRE). Permalink https://escholarship.org/uc/item/94p1n78c Journal Addiction biology, 25(2) ISSN 1355-6215 Authors Lai, Dongbing Wetherill, Leah Kapoor, Manav et al. Publication Date 2020-03-01 DOI 10.1111/adb.12800 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Received: 18 December 2018 Revised: 6 May 2019 Accepted: 27 May 2019 DOI: 10.1111/adb.12800 ORIGINAL ARTICLE Genome‐wide association studies of the self‐rating of effects of ethanol (SRE) Dongbing Lai1 | Leah Wetherill1 | Manav Kapoor2 | Emma C. Johnson3 | Melanie Schwandt4 | Vijay A. Ramchandani5 | David Goldman4 | Geoff Joslyn6 | Xi Rao1 | Yunlong Liu1 | Sean Farris7 | R. Dayne Mayfield7 | Danielle Dick8 | Victor Hesselbrock9 | John Kramer10 | Vivia V. McCutcheon3 | John Nurnberger1,11 | Jay Tischfield12 | Alison Goate2 | Howard J. Edenberg1,13 | Bernice Porjesz14 | Arpana Agrawal3 | Tatiana Foroud1 | Marc Schuckit15 1 Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana 2 Department of Neuroscience, Icahn School of Medicine at Mt. Sinai, New York, New York 3 Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri 4 Office of the Clinical Director, National Institute on Alcohol Abuse
    [Show full text]
  • CD29 Identifies IFN-Γ–Producing Human CD8+ T Cells With
    + CD29 identifies IFN-γ–producing human CD8 T cells with an increased cytotoxic potential Benoît P. Nicoleta,b, Aurélie Guislaina,b, Floris P. J. van Alphenc, Raquel Gomez-Eerlandd, Ton N. M. Schumacherd, Maartje van den Biggelaarc,e, and Monika C. Wolkersa,b,1 aDepartment of Hematopoiesis, Sanquin Research, 1066 CX Amsterdam, The Netherlands; bLandsteiner Laboratory, Oncode Institute, Amsterdam University Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands; cDepartment of Research Facilities, Sanquin Research, 1066 CX Amsterdam, The Netherlands; dDivision of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; and eDepartment of Molecular and Cellular Haemostasis, Sanquin Research, 1066 CX Amsterdam, The Netherlands Edited by Anjana Rao, La Jolla Institute for Allergy and Immunology, La Jolla, CA, and approved February 12, 2020 (received for review August 12, 2019) Cytotoxic CD8+ T cells can effectively kill target cells by producing therefore developed a protocol that allowed for efficient iso- cytokines, chemokines, and granzymes. Expression of these effector lation of RNA and protein from fluorescence-activated cell molecules is however highly divergent, and tools that identify and sorting (FACS)-sorted fixed T cells after intracellular cytokine + preselect CD8 T cells with a cytotoxic expression profile are lacking. staining. With this top-down approach, we performed an un- + Human CD8 T cells can be divided into IFN-γ– and IL-2–producing biased RNA-sequencing (RNA-seq) and mass spectrometry cells. Unbiased transcriptomics and proteomics analysis on cytokine- γ– – + + (MS) analyses on IFN- and IL-2 producing primary human producing fixed CD8 T cells revealed that IL-2 cells produce helper + + + CD8 Tcells.
    [Show full text]
  • SUPPLEMENTARY INFORMATION in Silico Signature Prediction
    SUPPLEMENTARY INFORMATION In Silico Signature Prediction Modeling in Cytolethal Distending Toxin-Producing Escherichia coli Strains Maryam Javadi, Mana Oloomi*, Saeid Bouzari Department of Molecular Biology, Pasteur Institute of Iran, Tehran 13164, Iran http://www.genominfo.org/src/sm/gni-15-69-s001.pdf Supplementary Table 6. Aalphabetic abbreviation and description of putative conserved domains Alphabetic Abbreviation Description 17 Large terminase protein 2_A_01_02 Multidrug resistance protein 2A0115 Benzoate transport; [Transport and binding proteins, Carbohydrates, organic alcohols] 52 DNA topisomerase II medium subunit; Provisional AAA_13 AAA domain; This family of domains contain a P-loop motif AAA_15 AAA ATPase domain; This family of domains contain a P-loop motif AAA_21 AAA domain AAA_23 AAA domain ABC_RecF ATP-binding cassette domain of RecF; RecF is a recombinational DNA repair ATPase ABC_SMC_barmotin ATP-binding cassette domain of barmotin, a member of the SMC protein family AcCoA-C-Actrans Acetyl-CoA acetyltransferases AHBA_syn 3-Amino-5-hydroxybenzoic acid synthase family (AHBA_syn) AidA Type V secretory pathway, adhesin AidA [Cell envelope biogenesis] Ail_Lom Enterobacterial Ail/Lom protein; This family consists of several bacterial and phage Ail_Lom proteins AIP3 Actin interacting protein 3; Aip3p/Bud6p is a regulator of cell and cytoskeletal polarity Aldose_epim_Ec_YphB Aldose 1-epimerase, similar to Escherichia coli YphB AlpA Predicted transcriptional regulator [Transcription] AntA AntA/AntB antirepressor AraC AraC-type
    [Show full text]
  • Open Matthew R Moreau Ph.D. Dissertation Finalfinal.Pdf
    The Pennsylvania State University The Graduate School Department of Veterinary and Biomedical Sciences Pathobiology Program PATHOGENOMICS AND SOURCE DYNAMICS OF SALMONELLA ENTERICA SEROVAR ENTERITIDIS A Dissertation in Pathobiology by Matthew Raymond Moreau 2015 Matthew R. Moreau Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy May 2015 The Dissertation of Matthew R. Moreau was reviewed and approved* by the following: Subhashinie Kariyawasam Associate Professor, Veterinary and Biomedical Sciences Dissertation Adviser Co-Chair of Committee Bhushan M. Jayarao Professor, Veterinary and Biomedical Sciences Dissertation Adviser Co-Chair of Committee Mary J. Kennett Professor, Veterinary and Biomedical Sciences Vijay Kumar Assistant Professor, Department of Nutritional Sciences Anthony Schmitt Associate Professor, Veterinary and Biomedical Sciences Head of the Pathobiology Graduate Program *Signatures are on file in the Graduate School iii ABSTRACT Salmonella enterica serovar Enteritidis (SE) is one of the most frequent common causes of morbidity and mortality in humans due to consumption of contaminated eggs and egg products. The association between egg contamination and foodborne outbreaks of SE suggests egg derived SE might be more adept to cause human illness than SE from other sources. Therefore, there is a need to understand the molecular mechanisms underlying the ability of egg- derived SE to colonize the chicken intestinal and reproductive tracts and cause disease in the human host. To this end, the present study was carried out in three objectives. The first objective was to sequence two egg-derived SE isolates belonging to the PFGE type JEGX01.0004 to identify the genes that might be involved in SE colonization and/or pathogenesis.
    [Show full text]
  • Roles of Methylation and Sequestration in the Mechanisms of DNA Replication in Some Members of the Enterobacteriaceae Family
    Chapter 12 Roles of Methylation and Sequestration in the Mechanisms of DNA Replication in some Members of the Enterobacteriaceae Family Amine Aloui, Alya El May, Saloua Kouass Sahbani and Ahmed Landoulsi Additional information is available at the end of the chapter http://dx.doi.org/10.5772/51724 1. Introduction When growing cells divide, they need to copy their genetic material and distribute it to en‐ sure that each daughter cell receives one copy. This is a challenging task especially when the enormous length of the DNA compared to the cell size is considered. During DNA replica‐ tion, organization of the chromosomes is even more demanding, since replication forks con‐ tinuously produce new DNA. This DNA contains all the information required to build the cells and tissues of a prokaryotic or an eukaryotic organism. The exact replication of this in‐ formation in any species assures its genetic continuity from generation to generation and is critical to the normal development of an individual. The information stored in DNA is ar‐ ranged in hereditary units known as genes that control the identifiable traits of an organism. Discovery of the structure of DNA and subsequent elucidation of how DNA directs synthe‐ sis of RNA, which then directs assembly of proteins -the so-called central dogma - were monumental achievements that marked the early days of molecular biology. However, the simplified representation of the central dogma as DNA → RNA → protein does not reflect the role of proteins in the synthesis of nucleic acids. Moreover, proteins are largely responsi‐ ble for regulating DNA replication and gene expression, the entire process whereby the in‐ formation encoded in DNA is decoded into the proteins that characterize various cell types.
    [Show full text]
  • Deciphering Bacterial Epigenomes Using Modern Sequencing Technologies
    REVIEWS Deciphering bacterial epigenomes using modern sequencing technologies John Beaulaurier, Eric E. Schadt and Gang Fang * Abstract | Prokaryotic DNA contains three types of methylation: N6-methyladenine, N4-methylcytosine and 5-methylcytosine. The lack of tools to analyse the frequency and distribution of methylated residues in bacterial genomes has prevented a full understanding of their functions. Now , advances in DNA sequencing technology , including single- molecule, real- time sequencing and nanopore- based sequencing, have provided new opportunities for systematic detection of all three forms of methylated DNA at a genome- wide scale and offer unprecedented opportunities for achieving a more complete understanding of bacterial epigenomes. Indeed, as the number of mapped bacterial methylomes approaches 2,000, increasing evidence supports roles for methylation in regulation of gene expression, virulence and pathogen–host interactions. Phase variation DNA methylation was discovered in bacteria more than MTases has been found to play important regulatory 1 2–12 A means by which reversible a half century ago . It is now known that modification roles in bacteria . RM systems protect cells from variation of protein expression of the four canonical DNA bases by methylation can act invading DNA by methylating endogenous DNA and is achieved in bacteria, often in as an epigenetic regulator — that is, it can impart dis- cleaving non- methylated foreign DNA2,4. RM sys- an ON/OFF manner. The process creates phenotypic tinct and reversible regulatory states to identical genetic tems are divided into three main categories based diversity in a clonally expanded sequences. In eukaryotes, epigenetic regulation can on the subunits involved and the precise site of DNA population and allows the occur at multiple levels: DNA methylation, nucleosome restriction13–16 (Fig.
    [Show full text]
  • The Microbiota-Produced N-Formyl Peptide Fmlf Promotes Obesity-Induced Glucose
    Page 1 of 230 Diabetes Title: The microbiota-produced N-formyl peptide fMLF promotes obesity-induced glucose intolerance Joshua Wollam1, Matthew Riopel1, Yong-Jiang Xu1,2, Andrew M. F. Johnson1, Jachelle M. Ofrecio1, Wei Ying1, Dalila El Ouarrat1, Luisa S. Chan3, Andrew W. Han3, Nadir A. Mahmood3, Caitlin N. Ryan3, Yun Sok Lee1, Jeramie D. Watrous1,2, Mahendra D. Chordia4, Dongfeng Pan4, Mohit Jain1,2, Jerrold M. Olefsky1 * Affiliations: 1 Division of Endocrinology & Metabolism, Department of Medicine, University of California, San Diego, La Jolla, California, USA. 2 Department of Pharmacology, University of California, San Diego, La Jolla, California, USA. 3 Second Genome, Inc., South San Francisco, California, USA. 4 Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA, USA. * Correspondence to: 858-534-2230, [email protected] Word Count: 4749 Figures: 6 Supplemental Figures: 11 Supplemental Tables: 5 1 Diabetes Publish Ahead of Print, published online April 22, 2019 Diabetes Page 2 of 230 ABSTRACT The composition of the gastrointestinal (GI) microbiota and associated metabolites changes dramatically with diet and the development of obesity. Although many correlations have been described, specific mechanistic links between these changes and glucose homeostasis remain to be defined. Here we show that blood and intestinal levels of the microbiota-produced N-formyl peptide, formyl-methionyl-leucyl-phenylalanine (fMLF), are elevated in high fat diet (HFD)- induced obese mice. Genetic or pharmacological inhibition of the N-formyl peptide receptor Fpr1 leads to increased insulin levels and improved glucose tolerance, dependent upon glucagon- like peptide-1 (GLP-1). Obese Fpr1-knockout (Fpr1-KO) mice also display an altered microbiome, exemplifying the dynamic relationship between host metabolism and microbiota.
    [Show full text]
  • PRMT3 (1-531, His-Tag) Human Protein – AR51778PU-N | Origene
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for AR51778PU-N PRMT3 (1-531, His-tag) Human Protein Product data: Product Type: Recombinant Proteins Description: PRMT3 (1-531, His-tag) human recombinant protein, 0.5 mg Species: Human Expression Host: E. coli Tag: His-tag Predicted MW: 62.3 kDa Concentration: lot specific Purity: >90% by SDS - PAGE Buffer: Presentation State: Purified State: Liquid purified protein Buffer System: Phosphate buffer saline (pH 7.4) containing 20% glycerol, 1mM DTT. Preparation: Liquid purified protein Protein Description: Recombinant human PRMT3, fused to His-tag at N-terminus, was expressed in E.coli and purified by using conventional chromatography techniques. Storage: Store undiluted at 2-8°C for one week or (in aliquots) at -20°C to -80°C for longer. Avoid repeated freezing and thawing. Stability: Shelf life: one year from despatch. RefSeq: NP_001138638 Locus ID: 10196 UniProt ID: Q8WUV3 Cytogenetics: 11p15.1 Synonyms: HRMT1L3 Summary: This gene belongs to the protein arginine methyltransferase (PRMT) family. The encoded enzyme catalyzes the methylation of guanidino nitrogens of arginyl residues of proteins. The enzyme acts on 40S ribosomal protein S2 (rpS2), which is its major in-vivo substrate, and is involved in the proper maturation of the 80S ribosome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013] This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 PRMT3 (1-531, His-tag) Human Protein – AR51778PU-N Protein Families: Druggable Genome Product images: This product is to be used for laboratory only.
    [Show full text]
  • Utilising Clinical Exome Sequencing in Patients with Rare Genetic Disease and Regions of Homozygosity Detected by SNP Microarray
    Utilising clinical exome sequencing in patients with rare genetic disease and regions of homozygosity detected by SNP microarray A thesis submitted to The University of Manchester for the degree of Doctor of Clinical Science In the faculty of Biology, Medicine and Health 2020 Lewis P Darnell School of Biological Sciences, Division of Cell Matrix Biology and Regenerative Medicine List of Contents Description Page Number Word count 7 List of figures 8 List of tables 9 List of abbreviations 10 Abstract 11 Declaration 12 Copyright statement 12 Acknowledgements 14 The author 15 1 Introduction 16 1.1 Introduction to Rare Genetic Disease 17 1.1.1 Rare Genetic Disorders 17 1.1.2 Diagnosing Rare Genetic Disorders 20 1.1.3 Consanguinity and Genetic Disease 22 1.2 Genetic Testing Methods 27 1.2.1 Microarray 27 1.2.2 DNA Sequencing 30 1.2.3 Whole Exome Sequencing 34 1.2.4 Clinical Exome Sequencing 38 1.2.5 Whole Genome Sequencing 41 1.2.6 Genetic Testing Summary 42 1.3 Variant Analysis 45 1.3.1 Variant Prioritisation 45 2 1.3.2 Variant Analysis 48 1.4 Genetic Testing for Rare Disease in the East Midlands 49 1.5 The Importance of this Research and Controversial Issues 53 1.6 Research Hypothesis 58 1.6.1 Research Question 58 1.6.2 Overarching Hypothesis 58 1.6.3 Specific Hypothesis 59 1.7 Detailed Project Aims 60 1.8 Evaluation of the Methodology Decision 62 1.9 Relevance to Research Area 64 1.10 Summary 65 2 Materials and Methods 67 2.1 Participants and Phenotypes 67 2.1.1 Participant Referral 67 2.1.2 Ethics and Consent 68 2.1.3 Participant Phenotypes,
    [Show full text]
  • A Tool for Clinical Management of Genetic Variants
    Wang et al. Genome Medicine (2015) 7:77 DOI 10.1186/s13073-015-0207-6 SOFTWARE Open Access ClinLabGeneticist: a tool for clinical management of genetic variants from whole exome sequencing in clinical genetic laboratories Jinlian Wang, Jun Liao, Jinglan Zhang, Wei-Yi Cheng, Jörg Hakenberg, Meng Ma, Bryn D. Webb, Rajasekar Ramasamudram-chakravarthi, Lisa Karger, Lakshmi Mehta, Ruth Kornreich, George A. Diaz, Shuyu Li, Lisa Edelmann* and Rong Chen* Abstract Routine clinical application of whole exome sequencing remains challenging due to difficulties in variant interpretation, large dataset management, and workflow integration. We describe a tool named ClinLabGeneticist to implement a workflow in clinical laboratories for management of variant assessment in genetic testing and disease diagnosis. We established an extensive variant annotation data source for the identification of pathogenic variants. A dashboard was deployed to aid a multi-step, hierarchical review process leading to final clinical decisions on genetic variant assessment. In addition, a central database was built to archive all of the genetic testing data, notes, and comments throughout the review process, variant validation data by Sanger sequencing as well as the final clinical reports for future reference. The entire workflow including data entry, distribution of work assignments, variant evaluation and review, selection of variants for validation, report generation, and communications between various personnel is integrated into a single data management platform. Three case studies are presented to illustrate the utility of ClinLabGeneticist. ClinLabGeneticist is freely available to academia at http://rongchenlab.org/software/clinlabgeneticist. Background effects, and testing of tumor biopsies to determine somatic Molecular genetic testing is playing an increasingly im- alterations for cancer classification, prognosis, and devel- portant role in medicine.
    [Show full text]
  • The Protein Arginine Methyltransferase PRMT5 Regulates Proliferation
    The Protein Arginine Methyltransferase PRMT5 Regulates Proliferation and the Expression of MITF and p27Kip1 in Human Melanoma DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University by Courtney Nicholas Graduate Program in Molecular, Cellular, and Developmental Biology The Ohio State University 2012 Dissertation Committee: Gregory B. Lesinski, PhD, Advisor Jiayuh Lin, PhD Amanda E. Toland, PhD Susheela Tridandapani, PhD Copyright by Courtney Nicholas 2012 Abstract The protein arginine methyltransferase-5 (PRMT5) enzyme is a Type II arginine methyltransferase that can regulate a variety of cellular functions. We hypothesized that PRMT5 plays a unique role in regulating the growth of human melanoma cells. Immunohistochemical analysis indicated significant upregulation of PRMT5 in human melanocytic nevi (88% of specimens positive for PRMT5), malignant melanomas (90% positive) and metastatic melanomas (88% positive) as compared to normal epidermis (5% of specimens positive for PRMT5; p<0.001, Fisher’s exact test). Furthermore, nuclear PRMT5 was significantly decreased in metastatic melanomas as compared to primary cutaneous melanomas (p<0.001, Wilcoxon rank sum test). Human metastatic melanoma cell lines in culture expressed PRMT5 predominantly in the cytoplasm. PRMT5 was found to be associated with its enzymatic cofactor Mep50, but not associated with STAT3 or cyclin D1. However, histologic examination of tumor xenografts from athymic mice revealed a heterogeneous pattern of nuclear and cytoplasmic PRMT5 expression. siRNA-mediated depletion of PRMT5 inhibited proliferation in a subset of melanoma cell lines, while it accelerated the growth of others. Loss of PRMT5 also led to reduced expression of MITF (microphthalmia-associated transcription factor), a melanocyte-lineage specific oncogene, and increased expression of the cell cycle regulator p27Kip1.
    [Show full text]